These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 18645404)
21. The outcomes of indocyanine green angiography monitored immunotherapy in Vogt-Koyanagi-Harada disease. Chee SP; Jap A Br J Ophthalmol; 2013 Feb; 97(2):130-3. PubMed ID: 23212203 [TBL] [Abstract][Full Text] [Related]
22. Treatment of Vogt-Koyanagi-Harada syndrome in pregnancy. Tien MC; Teoh SC Can J Ophthalmol; 2009 Apr; 44(2):211-2. PubMed ID: 19491962 [No Abstract] [Full Text] [Related]
23. Comparison of the clinical efficacy of two different immunosuppressive regimens in patients with chronic vogt-koyanagi-harada disease. Cuchacovich M; Solanes F; Díaz G; Cermenati T; Avila S; Verdaguer J; Verdaguer JI; Carpentier C; Stopel J; Rojas B; Traipe L; Gallardo P; Sabugo F; Zanoli M; Merino G; Villarroel F Ocul Immunol Inflamm; 2010 Jun; 18(3):200-7. PubMed ID: 20482399 [TBL] [Abstract][Full Text] [Related]
24. Basilar leptomeningitis in Vogt-Koyanagi-Harada disease. Loh Y Neurology; 2012 Feb; 78(6):438-9. PubMed ID: 22311930 [No Abstract] [Full Text] [Related]
25. Vogt-koyanagi-harada syndrome. Fang W; Yang P Curr Eye Res; 2008 Jul; 33(7):517-23. PubMed ID: 18600484 [TBL] [Abstract][Full Text] [Related]
26. Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt--Koyanagi--Harada disease. Errera MH; Fardeau C; Cohen D; Navarro A; Gaudric A; Bodaghi B; Westcott M; LeHoang P Acta Ophthalmol; 2011 Jun; 89(4):e357-66. PubMed ID: 21251241 [TBL] [Abstract][Full Text] [Related]
27. Bilateral conjunctival nodules: an unusual manifestation of Vogt-Koyanagi-Harada syndrome. Yang MC; Huang AJ Arch Ophthalmol; 2004 Dec; 122(12):1878-81. PubMed ID: 15596596 [No Abstract] [Full Text] [Related]
28. Vogt Koyanagi Harada disease: treatment and visual prognosis. Alam M; Iqbal M; Khan BS; Hussain I J Coll Physicians Surg Pak; 2013 Oct; 23(10):740-2. PubMed ID: 24112262 [TBL] [Abstract][Full Text] [Related]
29. Vogt-Koyanagi-Harada disease masquerading as a lymphoproliferative process of the uvea. Bhandari R; Dacey M; Schwartz S; Olson J; Quiroz-Mercado H; Mandava N; Oliver SC Br J Ophthalmol; 2013 Nov; 97(11):1482-3, 1489-90. PubMed ID: 23913248 [No Abstract] [Full Text] [Related]
30. Retinal cystoid spaces in acute Vogt-Koyanagi-Harada syndrome. de Smet MD; Rao NA Am J Ophthalmol; 2005 Nov; 140(5):962; author reply 962-3. PubMed ID: 16310504 [No Abstract] [Full Text] [Related]
31. [Long-term course of immunosuppressive therapy of Vogt-Koyanagi-Harada syndrome]. Wand K; Abraham S; Loos D; Stumpfe S; Lohmann C; Maier M; Feucht N Ophthalmologe; 2015 Oct; 112(10):857-60. PubMed ID: 25680347 [TBL] [Abstract][Full Text] [Related]
32. Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease. Urzua CA; Velasquez V; Sabat P; Berger O; Ramirez S; Goecke A; Vásquez DH; Gatica H; Guerrero J Acta Ophthalmol; 2015 Sep; 93(6):e475-80. PubMed ID: 25565265 [TBL] [Abstract][Full Text] [Related]